Event Brief
Mar 31, 2026 at 9:03 AM ET
Biogen to Acquire Apellis for $5.6 Billion
By The BriefBrief
Biogen is set to acquire Apellis Pharmaceuticals to enhance its kidney disease treatment portfolio.
WHO: Biogen
WHAT: acquire Apellis Pharmaceuticals
WHEN: Mar 31, 2026 at 8:07 AM ET
WHERE: USA
WHY: to expand work in kidney diseases
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
